Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

21.89 +0.46 (+2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,204,829
Open 21.30
Bid (Size) 21.87 (100)
Ask (Size) 22.20 (400)
Prev. Close 21.43
Today's Range 21.10 - 22.16
52wk Range 8.800 - 32.71
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kaplan Fox Continues to Remind Beta Bionics, Inc. (NASDAQ: BBNX) Investors of the Lead Plaintiff Deadline on November 3, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Robbins LLP Urges BBNX Stockholders Who Lost Money Investing in Beta Bionics, Inc. to Contact the Firm for Information About Leading the Class Action
From Robbins LLP
Via Business Wire

Performance

YTD
-25.2%
-25.2%
1 Month
+9.4%
+9.4%
3 Month
+59.8%
+59.8%
6 Month
+104.6%
+104.6%
1 Year
-5.0%
-5.0%

More News

Read More
News headline image
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) with Significant Losses to Seek a Leadership Role Before November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 3, 2026 Against Beta Bionics, Inc. (NASDAQ: BBNX)
Via NewMediaWire
Topics Lawsuit
News headline image
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Continues to Alert Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Class Action Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
BETA BIONICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery of the Lead Plaintiff Deadline on November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Did You Lose Money Investing in Beta Bionics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against BBNX
Via Newsfile
Topics Lawsuit
News headline image
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) Who Suffered Losses to Contact the Firm Before November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Deadline Approaching: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 3, 2026 - BBNX
From Levi & Korsinsky, LLP
Via Business Wire

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?
Yes, Beta Bionics, Inc. - Common Stock is publicly traded.
What exchange does Beta Bionics, Inc. - Common Stock trade on?
Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Beta Bionics, Inc. - Common Stock?
The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market
What is the current price of Beta Bionics, Inc. - Common Stock?
The current price of Beta Bionics, Inc. - Common Stock is 21.89
When was Beta Bionics, Inc. - Common Stock last traded?
The last trade of Beta Bionics, Inc. - Common Stock was at 09/18/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.